Moderna Inc (MRNA)

123.64
-0.68(-0.55%)
Pre Market
123.30
-0.34(-0.27%)
- Real-time Data
  • Volume:
    3,942,637
  • Day's Range:
    121.25 - 125.01
  • 52 wk Range:
    115.61 - 434.00

MRNA Overview

Prev. Close
124.32
Day's Range
121.25-125.01
Revenue
22.6B
Open
122.81
52 wk Range
115.61-434
EPS
34.96
Volume
3,942,637
Market Cap
48.37B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
4,873,691
P/E Ratio
4.24
Beta
1.6
1-Year Change
-71.26%
Shares Outstanding
391,199,544
Next Earnings Date
02 Nov 2022
What is your sentiment on Moderna?
or
Market is currently closed. Voting is open during market hours.

Moderna Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Moderna Inc Analysis

Moderna Inc Company Profile

Moderna Inc Company Profile

Employees
2700

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Read More

Analyst Price Target

Average219.33 (+77.40% Upside)
High506
Low70
Price123.64
No. of Analysts15
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyNeutralSellStrong SellSell
Technical IndicatorsStrong BuyBuyStrong SellStrong SellStrong Sell
SummaryStrong BuyNeutralStrong SellStrong SellStrong Sell